Home >> WEBINARS >> Current and emerging biomarkers: science, technologies, and practicalities

Current and emerging biomarkers: science, technologies, and practicalities

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenter Sam Caughron, MD, President & Managing Partner, Director of Molecular Lab, MAWD Pathology Group, Kansas City, Missouri, discusses Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This on-demand webinar originally broadcast on November 29, 2018.

CAP TODAY does not endorse any of the products or services named within.
This webinar is made possible with support of Bristol-Myers Squibb. IOUS1802863-01

x

Check Also

MALDI-TOF for the clinical identification of mycobacteria

Webinar presenter Omai Garner, PhD, D(ABMM), Assistant Clinical Professor, Section Chief, Clinical Microbiology, Director, Point of Care Testing, UCLA Department of Pathology and Laboratory Medicine,  discusses the implementation and clinical use of MALDI-TOF MS for mycobacterial identification. It covers in detail the clinical data surrounding organism identification. It also explores the lab protocol (workflow impact) and turnaround time improvements (clinical impact) for this new technology. This on-demand webinar originally broadcast on December 13, 2018.

X